Sana Biotechnology Inc (SANA)
10.44
+0.66
(+6.75%)
USD |
NASDAQ |
May 03, 16:00
10.44
0.00 (0.00%)
After-Hours: 20:00
Sana Biotechnology Cash from Operations (TTM): -253.58M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -253.58M |
September 30, 2023 | -277.69M |
June 30, 2023 | -278.94M |
March 31, 2023 | -291.61M |
December 31, 2022 | -290.05M |
September 30, 2022 | -324.08M |
June 30, 2022 | -309.77M |
Date | Value |
---|---|
March 31, 2022 | -278.85M |
December 31, 2021 | -251.05M |
September 30, 2021 | -178.51M |
June 30, 2021 | -165.54M |
March 31, 2021 | -158.35M |
December 31, 2020 | -137.98M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-324.08M
Minimum
Sep 2022
-137.98M
Maximum
Dec 2020
-245.85M
Average
-277.69M
Median
Sep 2023
Cash from Operations (TTM) Benchmarks
Rocket Pharmaceuticals Inc | -194.92M |
Solid Biosciences Inc | -94.18M |
Dyne Therapeutics Inc | -219.79M |
Taysha Gene Therapies Inc | -73.02M |
Tenaya Therapeutics Inc | -102.07M |